Valeant Pharmaceuticals International Closes $425 Million Unit Sale to Meda AB

ALISO VIEJO, Calif. -Drug maker Valeant Pharmaceuticals Inc. said Friday it completed the sale of its Eastern and Western European businesses to Meda AB of Sweden.

MORE ON THIS TOPIC